What laboratory values are typically out of range in patients with Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Values Typically Out of Range in PCOS Diagnosis

The most common laboratory abnormalities in PCOS include elevated LH/FSH ratio (>2), elevated total testosterone (>2.5 nmol/L), low progesterone (<6 nmol/L), and markers of insulin resistance such as abnormal glucose/insulin ratio (>4). 1

Key Hormonal Abnormalities

Gonadotropins

  • LH/FSH ratio: Often elevated >2 in PCOS patients 1, 2
  • LH levels: Frequently elevated (>11 IU/L) 1
  • FSH levels: Usually normal or slightly decreased 3

Androgens

  • Total testosterone: Most frequently abnormal marker (elevated >2.5 nmol/L in 70% of PCOS cases) 1, 4
  • Free testosterone: Typically elevated 1, 5
  • Androstenedione: Elevated (>10.0 nmol/L) in approximately 53% of cases 1, 4
  • DHEAS: May be elevated, particularly in younger women (>3800 ng/ml for ages 20-29, >2700 ng/ml for ages 30-39) 1

Other Sex Hormones

  • Progesterone: Low mid-luteal phase levels (<6 nmol/L), indicating anovulation 1
  • Sex hormone-binding globulin (SHBG): Often decreased, especially in obese patients 2, 5

Metabolic Parameters

Insulin Resistance Markers

  • Glucose/insulin ratio: Decreased (<4), suggesting reduced insulin sensitivity 1, 2
  • Fasting glucose: May be elevated (>7.8 mmol/L) 1
  • Fasting insulin: Often elevated 5

Clinical Pearls and Pitfalls

  • Most sensitive single marker: Total testosterone is the most frequently abnormal biochemical marker (70% sensitivity) 4
  • Combination testing: Using testosterone, androstenedione, and LH in combination increases detection to 86% of PCOS cases 4
  • LH/FSH ratio limitations: While traditionally emphasized, this ratio has lower sensitivity (41-44%) than previously thought 4
  • Timing matters: Hormone levels should be measured between days 3-6 of the menstrual cycle for accurate assessment 1
  • Assay variability: Different laboratory methods can yield significantly different absolute values, particularly for gonadotropins 4
  • Obesity impact: Obesity affects hormone levels in PCOS, particularly decreasing SHBG levels 5, 6

Recommended Laboratory Panel for PCOS Diagnosis

  1. First-line tests:

    • Total testosterone
    • Free testosterone
    • LH and FSH (with ratio calculation)
    • Progesterone (mid-luteal phase)
    • Thyroid-stimulating hormone (TSH)
    • Prolactin 2
  2. Additional metabolic assessment:

    • Fasting glucose/insulin ratio
    • Lipid profile
    • 2-hour 75g oral glucose tolerance test (particularly for BMI >25 kg/m²) 2
  3. Further testing as indicated:

    • Androstenedione
    • DHEAS
    • 17-hydroxyprogesterone (to rule out non-classical adrenal hyperplasia) 1, 2

Remember that laboratory findings must be correlated with clinical features and ultrasound findings for proper PCOS diagnosis according to Rotterdam criteria, as no single test is diagnostic 2, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Polycystic Ovary Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hormonal changes in PCOS.

The Journal of endocrinology, 2024

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.